Literature DB >> 15378228

Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels.

Vincenzo Calderone1, Silvio Chericoni, Cinzia Martinelli, Lara Testai, Antonio Nardi, Ivano Morelli, Maria Cristina Breschi, Enrica Martinotti.   

Abstract

A flavonoid-rich diet has been associated with a lower incidence of cardiovascular diseases, probably because of the antioxidant and vasoactive properties of flavonoids. Indeed, many flavonoids show vasorelaxing properties, due to different and often not yet completely clarified mechanisms of action. Among them, the activation of vascular potassium channels has been indicated as a possible pathway, accounting, at least in part, for the vasodilatory action of some flavonoid derivatives, such as apigenin and dioclein. Therefore, this work aims at evaluating, on in vitro isolated rat aortic rings, the endothelium-independent vasorelaxing effects of a number of flavonoid derivatives, to identify a possible activation of calcium-activated and/or ATP-sensitive potassium channels and to indicate some possible structure-activity relationships. Among the several flavonoids submitted to the pharmacological assay, only baicalein and quercetagetin were almost completely ineffective, while quercetin, hesperidin, quercitrin and rhoifolin exhibited only a partial vasorelaxing effect. On the contrary, acacetin, apigenin, chrysin, hesperetin, luteolin, pinocembrin, 4'-hydroxyflavanone, 5-hydroxyflavone, 5-methoxyflavone, 6-hydroxyflavanone and 7-hydroxyflavone, belonging to the chemical classes of flavones and flavanones, showed full vasorelaxing effects. The vasodilatory activity of hesperetin, luteolin, 5-hydroxyflavone and 7-hydroxyflavone were antagonised by tetraethylammonium chloride, indicating the possible involvement of calcium-activated potassium channels. Moreover, iberiotoxin clearly antagonised the effects of 5-hydroxyflavone, indicating the probable importance of a structural requirement (the hydroxy group in position 5) for a possible interaction with large-conductance, calcium-activated potassium channels. Finally, glibenclamide inhibited the vasorelaxing action of luteolin and 5-hydroxyflavone, suggesting that ATP-sensitive potassium channels may also be involved in their mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378228     DOI: 10.1007/s00210-004-0964-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

1.  Novel openers of Ca2+-dependent large-conductance potassium channels: symmetrical pharmacophore and electrophysiological evaluation of bisphenols.

Authors:  Yi Li; Graham Johnson; Jeffrey L Romine; Nicholas A Meanwell; Scott W Martin; Steven I Dworetzky; Christopher G Boissard; Valentin K Gribkoff; John E Starrett
Journal:  Bioorg Med Chem Lett       Date:  2003-04-17       Impact factor: 2.823

Review 2.  Large-conductance, ca(2+)-activated k(+) channels: function, pharmacology and drugs.

Authors:  V Calderone
Journal:  Curr Med Chem       Date:  2002-07       Impact factor: 4.530

Review 3.  Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis.

Authors:  M Aviram; B Fuhrman
Journal:  Atherosclerosis       Date:  1998-04       Impact factor: 5.162

4.  Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta.

Authors:  C Löffler; U Quast
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

5.  Enhanced role for the opening of potassium channels in relaxant responses to acetylcholine after myocardial ischaemia and reperfusion in dog coronary arteries.

Authors:  E C Chan; O L Woodman
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  BK(Ca) channels compensate for loss of NOS-dependent coronary artery relaxation in cardiomyopathy.

Authors:  S G Clark; L C Fuchs
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

7.  Effects of flavonoids on rat aortic smooth muscle contractility: structure-activity relationships.

Authors:  M D Herrera; A Zarzuelo; J Jiménez; E Marhuenda; J Duarte
Journal:  Gen Pharmacol       Date:  1996-03

8.  Influence of depolarization on vasorelaxant potency and efficacy of Ca2+ entry blockers, K+ channel openers, nitrate derivatives, salbutamol and papaverine in rat aortic rings.

Authors:  M Magnon; V Calderone; A Floch; I Cavero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1998-10       Impact factor: 3.000

Review 9.  KATP channel openers: structure-activity relationships and therapeutic potential.

Authors:  Raimund Mannhold
Journal:  Med Res Rev       Date:  2004-03       Impact factor: 12.944

10.  The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004.

Authors:  C A Sargent; G J Grover; M J Antonaccio; J R McCullough
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

View more
  26 in total

1.  Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels.

Authors:  Vincenzo Calderone; Alma Martelli; Lara Testai; Enrica Martinotti; Maria C Breschi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-04       Impact factor: 3.000

2.  Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin.

Authors:  Francisco Orallo; Ezequiel Alvarez; Hélène Basaran; Claire Lugnier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-17       Impact factor: 3.000

3.  A cell-based phenotypic assay to identify cardioprotective agents.

Authors:  Stephanie Guo; Adam Olm-Shipman; Andrew Walters; William R Urciuoli; Stefanie Devito; Sergiy M Nadtochiy; Andrew P Wojtovich; Paul S Brookes
Journal:  Circ Res       Date:  2012-03-06       Impact factor: 17.367

4.  Modulatory Effect of Selected Dietary Phytochemicals on Delayed Rectifier K+ Current in Human Prostate Cancer Cells.

Authors:  Kiran George; Nisha Susan Thomas; Raman Malathi
Journal:  J Membr Biol       Date:  2019-06-04       Impact factor: 1.843

5.  In vivo antioxidative effect of isoquercitrin on cadmium-induced oxidative damage to mouse liver and kidney.

Authors:  Ruijin Li; Chao Yuan; Chuan Dong; Shaomin Shuang; Martin M F Choi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-19       Impact factor: 3.000

6.  (+/-)-Naringenin as large conductance Ca(2+)-activated K+ (BKCa) channel opener in vascular smooth muscle cells.

Authors:  S Saponara; L Testai; D Iozzi; E Martinotti; A Martelli; S Chericoni; G Sgaragli; F Fusi; V Calderone
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

7.  Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.

Authors:  Huan Wang; Hong-Fei Wang; Hao Zhang; Chen Wang; Yu-Fang Chen; Rong Ma; Ji-Zhou Xiang; Xin-Ling Du; Qiang Tang
Journal:  Acta Pharmacol Sin       Date:  2016-10-03       Impact factor: 6.150

8.  The flavonoid luteolin induces nitric oxide production and arterial relaxation.

Authors:  Hongwei Si; Richard P Wyeth; Dongmin Liu
Journal:  Eur J Nutr       Date:  2013-04-21       Impact factor: 5.614

9.  Possible Involvement of Ca Activated K Channels, SK Channel, in the Quercetin-Induced Vasodilatation.

Authors:  Seiichiro Nishida; Hiroyasu Satoh
Journal:  Korean J Physiol Pharmacol       Date:  2009-10-31       Impact factor: 2.016

10.  Evaluation of the intravenous and topical routes for ocular delivery of hesperidin and hesperetin.

Authors:  Ramesh Srirangam; Ketan Hippalgaonkar; Bharathi Avula; Ikhlas A Khan; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2012-07-13       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.